Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Celldex (CLDX) Ownership Overview
0.36% Insiders
36.04% Mutual Funds
41.42% Other Institutional Investors
13.22% ETFs
8.96% Public Companies and Individual Investors
The ownership structure of Celldex (CLDX) stock is a mix of institutional, retail, and individual investors. Approximately 90.68% of the company’s stock is owned by Institutional Investors, 0.36% is owned by Insiders, and 8.96% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 18, 2024 | Samuel Bates Martin Svp And Cfo | xxxxxxxxxxxxx | $608232 |
| Jun 18, 2024 | Elizabeth Crowley Sr. Vp & Cpdo | xxxxxxxxxxxxx | $1045800 |
| Jun 11, 2024 | Elizabeth Crowley Sr. Vp & Cpdo | xxxxxxxxxxxxx | $525750 |
| Jun 11, 2024 | Diane Young Svp, Chief Medical Officer | xxxxxxxxxxxxx | $1586700 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $11434599 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $50894159 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,547,257 | Institution | 6.85% | 103,222,734 | |
| 3,640,477 | Institution | 5.49% | 82,638,828 | |
| 3,352,884 | Institution | 5.05% | 76,110,467 | |
| 3,071,673 | Institution | 4.63% | 69,726,977 | |
| 2,541,670 | Institution | 3.83% | 57,695,909 | |
| 2,341,121 | Institution | 3.53% | 53,143,447 | |
| 1,776,708 | Institution | 2.68% | 40,331,272 | |
| 1,444,374 | Institution | 2.18% | 32,787,290 | |
| 1,323,404 | Institution | 1.99% | 30,041,271 | |
| 1,132,864 | Institution | 1.71% | 25,716,013 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,547,257 | Institution | 6.85% | 103,222,734 | |
| 3,352,884 | Institution | 5.05% | 76,110,467 | |
| 3,071,673 | Institution | 4.63% | 69,726,977 | |
| 1,444,374 | Institution | 2.18% | 32,787,290 | |
| 1,323,404 | Institution | 1.99% | 30,041,271 | |
| 1,132,864 | Institution | 1.71% | 25,716,013 | |
| 1,051,077 | Institution | 1.58% | 23,859,448 | |
| 764,252 | Institution | 1.15% | 17,348,520 | |
| 761,430 | Institution | 1.15% | 17,284,461 | |
| 710,664 | Institution | 1.07% | 16,132,073 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,081,251 | Institution | 3.14% | 52,593,213 | |
| 1,734,805 | Institution | 2.61% | 39,380,074 | |
| 1,638,103 | Institution | 2.47% | 37,774,655 | |
| 997,167 | Institution | 1.50% | 25,198,410 | |
| 468,962 | Institution | 0.71% | 10,645,437 | |
| 317,925 | Institution | 0.48% | 7,331,351 | |
| 306,218 | Institution | 0.46% | 7,738,129 | |
| 194,405 | Institution | 0.29% | 4,912,614 | |
| 110,564 | Institution | 0.17% | 2,509,803 | |
| 76,379 | Institution | 0.12% | 1,733,803 |
FAQ
Who Owns Celldex Therapeutics Inc (CLDX)?
According to the latest TipRanks data, approximately 41.42% of the company's stock is held by institutional investors, 0.36% is held by insiders, and 8.96% is held by retail investors.
What percentage of Celldex Therapeutics Inc (CLDX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 41.42% of Celldex Therapeutics Inc (CLDX) stock is held by institutional investors.
What percentage of Celldex Therapeutics Inc (CLDX) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.96% of Celldex Therapeutics Inc (CLDX) stock is held by retail investors.
Who owns the most shares of Celldex Therapeutics Inc (CLDX)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Celldex Therapeutics Inc (CLDX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.